Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)

TYO:4530 Revenue

Hisamitsu Pharmaceutical Co. had revenue of 39.57B JPY in the quarter ending November 30, 2025, with 10.54% growth. This brings the company's revenue in the last twelve months to 159.27B, up 6.08% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.

• Revenue (ttm): 159.27B
• Revenue Growth: +6.08%
• P/S Ratio: 2.78
• Revenue / Employee: 56.90M
• Employees: 2,799
• Market Cap: 442.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	156.01B	14.30B	10.09%
Feb 29, 2024	141.71B	13.38B	10.42%
Feb 28, 2023	128.33B	8.14B	6.77%
Feb 28, 2022	120.19B	5.68B	4.96%
Feb 28, 2021	114.51B	-26.48B	-18.78%